Patient Clinical Data |
Age/Sex |
Symptoms at presentation |
Drain settings |
Symptoms at 24h postop |
Discharge disposition |
Symptoms at follow-up |
82 M |
Right-sided weakness and hemineglect, mental deterioration |
Drain at 0, 1.5cc/hr |
Full strength, oriented x3 |
Home |
Two weeks: Full strength, mild discoordination and difficulty speaking |
78 M |
Mild left upper extremity weakness (4+/5), incoordination |
Drain at 0, 10cc/hr |
Full strength, oriented x3 |
Home |
10 days: L hand paresthesia, full strength. Five weeks: Subjective L hand weakness, on Keppra 500mg Three months: Normal exam, no complaints, continued Keppra One year: Normal exam, no complaints, stopped Keppra |
83 M |
Mild global weakness, mental deterioration, pupillary asymmetry |
Drain at -5, 100cc/hr -> 40cc/hr (POD1) |
Equal/reactive pupils. minimal residual weakness |
Home |
Two weeks: Complete resolution of preoperative neurologic deficits |
78 M |
Left-sided weakness with pronator drift |
Drain at 0, 90cc/hr |
Full strength, oriented x3 |
ARU |
Two weeks: no complaints. Normal neurologic exam 3 months: Remains asymptomatic |
89 M |
Right upper extremity hypertonia, incoordination, mental deterioration |
Drain at 0, 30cc/hr |
Improved cognition, no formal motor examination |
SNF |
Five days: Returned to hospital for seizure, improved with medical management Three months: No focal weakness (global 4+/5) Nine months: full strength, no further seizures despite stopping Keppra four months prior |
75 M |
Mild left upper extremity weakness (4+/5) with pronator drift, incoordination |
Drain at 0, 100cc/hr |
Minimal residual weakness, no pronator drift |
ARU |
Two weeks: Complete resolution of preoperative neurologic deficits |